Peginterferon alfa-2b biosimilar (Phage Pharmaceuticals)

聚乙二醇干扰素α-2b生物类似药 (Phage Pharmaceuticals)

Report date: 2025/12/26 09:46:10

Base Information

Drug NamePeginterferon alfa-2b biosimilar (Phage Pharmaceuticals)
Drug Alias NamePEG-Interferon alpha 2b (Phage Pharmaceuticals)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPhage Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhage Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHepatitis

Other Information

ATC CodeN/A
Related LinksN/A